CombiMatrix Molecular Diagnostics And Array Genomics Collaborate To Expand Diagnostic Microarray Technology Internationally

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--March 13, 2006--Acacia Research Corporation (NASDAQ:CBMX) (NASDAQ:ACTG) announced today that its CombiMatrix group’s subsidiary, CombiMatrix Molecular Diagnostics (CMDX), and Array Genomics Inc. (AG), Nr. Paris, France, will co-develop, market, and sell an exciting new series of comparative genomic hybridization (CGH) microarray products and services internationally, using expertise and technology from both companies.

MORE ON THIS TOPIC